Literature DB >> 26714657

Parkinson disease. Unravelling the nonmotor mysteries of Parkinson disease.

K Ray Chaudhuri1, Anna Sauerbier1.   

Abstract

Parkinson disease (PD) is now regarded as a mixed motor, nonmotor and multiorgan disorder rather than a pure movement disorder. Nonmotor symptoms (NMS) have underpinned this conceptual change, and new criteria for clinical and prodromal diagnosis of PD, incorporating a range of NMS, have recently been published.

Entities:  

Mesh：

Year:  2016        PMID： 26714657     DOI： 10.1038/nrneurol.2015.236

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


  9 in total

Review 1.  MDS clinical diagnostic criteria for Parkinson's disease.

Authors:  Ronald B Postuma; Daniela Berg; Matthew Stern; Werner Poewe; C Warren Olanow; Wolfgang Oertel; José Obeso; Kenneth Marek; Irene Litvan; Anthony E Lang; Glenda Halliday; Christopher G Goetz; Thomas Gasser; Bruno Dubois; Piu Chan; Bastiaan R Bloem; Charles H Adler; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

Review 2.  MDS research criteria for prodromal Parkinson's disease.

Authors:  Daniela Berg; Ronald B Postuma; Charles H Adler; Bastiaan R Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda Halliday; Lawrence Joseph; Anthony E Lang; Inga Liepelt-Scarfone; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

Review 3.  Non-motor symptoms of Parkinson's disease: diagnosis and management.

Authors:  K Ray Chaudhuri; Daniel G Healy; Anthony H V Schapira
Journal:  Lancet Neurol       Date:  2006-03       Impact factor: 44.182

4.  Imaging amyloid deposition in Lewy body diseases.

Authors:  S N Gomperts; D M Rentz; E Moran; J A Becker; J J Locascio; W E Klunk; C A Mathis; D R Elmaleh; T Shoup; A J Fischman; B T Hyman; J H Growdon; K A Johnson
Journal:  Neurology       Date:  2008-09-16       Impact factor: 9.910

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 6.  Non motor subtypes and Parkinson's disease.

Authors:  Anna Sauerbier; Peter Jenner; Antoniya Todorova; K Ray Chaudhuri
Journal:  Parkinsonism Relat Disord       Date:  2015-09-11       Impact factor: 4.891

Review 7.  The prodromal phase of sporadic Parkinson's disease: does it exist and if so how long is it?

Authors:  Christopher H Hawkes
Journal:  Mov Disord       Date:  2008-10-15       Impact factor: 10.338

8.  Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.

Authors:  Anette Schrag; Laura Horsfall; Kate Walters; Alastair Noyce; Irene Petersen
Journal:  Lancet Neurol       Date:  2014-11-27       Impact factor: 44.182

Review 9.  Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Authors:  Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag
Journal:  Ann Neurol       Date:  2012-10-15       Impact factor: 10.422
  9 in total
  8 in total

Review 1.  [Diagnostics of clinical and prodromal idiopathic Parkinson's disease : New criteria].

Authors:  H Zach; U Walter; I Liepelt-Scarfone; W Maetzler
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 2.  Cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Byron Creese; Marios Politis; K Ray Chaudhuri; Dominic H Ffytche; Daniel Weintraub; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2017-03-03       Impact factor: 42.937

Review 3.  Classification of advanced stages of Parkinson's disease: translation into stratified treatments.

Authors:  Rejko Krüger; Jochen Klucken; Daniel Weiss; Lars Tönges; Pierre Kolber; Stefan Unterecker; Michael Lorrain; Horst Baas; Thomas Müller; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2017-03-24       Impact factor: 3.575

4.  Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease-Viewpoint.

Authors:  Carolina Sportelli; Daniele Urso; Peter Jenner; K Ray Chaudhuri
Journal:  Front Neurol       Date:  2020-06-12       Impact factor: 4.003

5.  α-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson's disease.

Authors:  Samanta Mazzetti; Milo J Basellini; Valentina Ferri; Erica Cassani; Emanuele Cereda; Matilde Paolini; Alessandra M Calogero; Carlotta Bolliri; Mara De Leonardis; Giorgio Sacilotto; Roberto Cilia; Graziella Cappelletti; Gianni Pezzoli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

Review 6.  Systematic review for the prevention and management of falls and fear of falling in patients with Parkinson's disease.

Authors:  Wen-Yi Liu; Tao-Hsin Tung; Chencheng Zhang; Leiyu Shi
Journal:  Brain Behav       Date:  2022-07-14       Impact factor: 3.405

Review 7.  Efficacy and safety of 3-n-butylphthalide for the treatment of cognitive impairment: A systematic review and meta-analysis.

Authors:  Qiulu Zhou; Chao Han; Yun Xia; Fang Wan; Sijia Yin; Yunna Li; Liang Kou; Xiaosa Chi; Junjie Hu; Yadi Sun; Jiawei Wu; Wenkai Zou; Jinsha Huang; Tao Wang
Journal:  CNS Neurosci Ther       Date:  2022-09-01       Impact factor: 7.035

Review 8.  Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.

Authors:  Steven D Mitchell; Christos Sidiropoulos
Journal:  Toxins (Basel)       Date:  2021-03-19       Impact factor: 4.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.